Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page
- Check4 days agoChange DetectedRemoved the government funding/operational status notice from the page; core study details and related content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoChange DetectedNo significant changes detected in core study content such as title, conditions, interventions, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check47 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior version tag v3.1.0 was removed.SummaryDifference5%

- Check54 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check69 days agoChange DetectedVersion bumped to v3.0.2 and the Back to Top element was removed; core content and critical data remain unchanged.SummaryDifference0.3%

- Check76 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.